Dr. Paik’s clinical and research interests center on neuromuscular manifestations of autoimmune diseases, particularly myositis and scleroderma. Her current research focuses on the mechanisms of ...
Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range ...
Juvenile dermatomyositis (JDM) is a rare autoimmune condition with insufficient biomarkers and treatments, in part, due to incomplete knowledge of the cell types mediating disease. We investigated ...
We aimed to evaluate risk factors for SSc‐pHI and its progression and the outcomes in the EUSTAR (European Scleroderma Trials and Research) cohort. Risk factors for the presence of SSc‐pHI comprised ...
Dr. Paik’s clinical and research interests center on neuromuscular manifestations of autoimmune diseases, particularly myositis and scleroderma. Her current research focuses on the mechanisms of ...
Indeed, systemic sclerosis is a heterogeneous disease, the two predominant forms of the disease being limited and diffuse scleroderma. Autoimmune myositis is also a heterogeneous group of myopathies ...
Systemic scleroderma is an autoimmune disease caused by the immune system attacking the body’s connective tissues, which provide the body with structural support. Immune cells called T cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback